Box containing ten disposable syringes, each prefilled with 1ml of Engerix B Vaccine, bioengineered and grown in yeast, for intramuscular injection to protect against Hepatitis B, by SmithKline Beecham Pharmaceuticals, Welwyn Garden City, England, 1993
Hepatitis B is a disease that causes inflammation of the liver. Long term effects include liver diseases and liver cancer. The vaccine was introduced in the 1980s. It is thought that immunity from vaccination is for life, although this has not been confirmed. ‘Engerix B’ was the first commercially made and sold bio-engineered vaccine. Made by SmithKline Beecham Pharmaceuticals, the vaccine was grown in yeast.
- Public Health & Hygiene
- Object Number:
- 1994-139 Pt2
syringe: 102 mm x 22 mm x 30 mm, .1 kg
box: 135 mm x 116 mm x 36 mm, .06 kg
- furnishing and equipment
- tools & equipment
- medical instrument
Cite this page
We encourage the use and reuse of our collection data.
Data in the title, made, maker and details fields are released under Creative Commons Zero
Descriptions and all other text content are licensed under a Creative Commons Attribution 4.0 licence
Download catalogue entry as json
View manifest in IIIF viewer
Download manifest IIIF
Our records are constantly being enhanced and improved, but please note that we cannot guarantee the accuracy of any information shown on this website.